Motilal Oswal reiterated a "Buy" rating for Biocon with a price target of Rs520. The target has been revised but positive view on the stock remains intact.

Deven Choksey Research has issued an ACCUMULATE rating on Cipla Ltd, setting a target price of Rs 1,589 against a current market price of Rs 1,432 — an implied upside of 11%.

Geojit Investments Limited has maintained a BUY rating on Strides Pharma Science Ltd.

ICICI Securities has maintained its HOLD rating on Torrent Pharma, nudging up its 12-month target price to Rs 4,800 from Rs 4,600 earlier — a modest 4% upside from

Geojit Financial Services has reiterated an ACCUMULATE rating on Mankind Pharma Limited with a revised 12-month target price of Rs.

Geojit Financial Services has reiterated its BUY recommendation on Lupin Limited, raising the target price to Rs 2,606 from the current market price of Rs 2,261, implying a potential upside of near